EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)

Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial

Louise F Risnes iD, Margit Brottveit, Ida Robertsen, Jostein Ibsen, Lars Aabakken, Marie K Johannesen, Stine R Lund, Siv K B Furholm, Siv E H Isaksen, Anders Åsberg, Ludvig M Sollid, Knut E A Lundin

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70301 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Louise F Risnes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Norwegian Centre for Coeliac Disease Research, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Celiac Disease, Toluidines, Crotonates, Glutens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Aktieselskabet Freia Chocolade Fabriks Medisinske fond, Stiftelsen K.G. Jebsen, Oslo University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coeliac disease is an autoimmune disorder driven by gluten and managed through a strict gluten‐free diet. We tested teriflunomide, a drug known for its ability to alter T‐cell activity, in a phase 2a trial of 15 patients with coeliac disease. Participants received teriflunomide or placebo including a loading dose, followed by a 3‐day oral gluten challenge to monitor T‐cell responses. The main aim was to observe attenuation of gluten‐specific T‐cell activation markers after gluten exposure. We found no significant differences in T‐cell activity between groups, concluding that teriflunomide is ineffective as a non‐dietary treatment for coeliac disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseToluidinesCrotonatesGlutensT-LymphocytesHumansNitrilesHydroxybutyratesMaleFemaleAdultMiddle AgedDiet, Gluten-FreeDouble-Blind Method

Substanzen

NitrilesteriflunomideHydroxybutyratesToluidinesCrotonatesGlutens

Autor:innen und Institutionen

  • Norwegian Centre for Coeliac Disease Research, University of Oslo, Oslo, Norway.
  • Department of Immunology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
  • Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
  • Department of Gastroenterology, Oslo University Hospital-Ullevål, Oslo, Norway.
  • Department of Pharmacy, University of Oslo, Oslo, Norway.

ORCID-Profile: Louise F Risnes

Förderung

  • Aktieselskabet Freia Chocolade Fabriks Medisinske fond
  • Stiftelsen K.G. Jebsen
  • Oslo University Hospital
  • Universitetet i Oslo
  • Oslo universitetssykehus HF

Zitieren

APA

Risnes, L. F., Brottveit, M., Robertsen, I., Ibsen, J., Aabakken, L., Johannesen, M. K., Lund, S. R., Furholm, S. K. B., Isaksen, S. E. H., Åsberg, A., Sollid, L. M., & Lundin, K. E. A. (2025). Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70301

Vancouver

Risnes LF, Brottveit M, Robertsen I, Ibsen J, Aabakken L, Johannesen MK, et al. Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70301

BibTeX
@article{Risnes2025,
  author = {Risnes, Louise F and Brottveit, Margit and Robertsen, Ida and Ibsen, Jostein and Aabakken, Lars and Johannesen, Marie K and Lund, Stine R and Furholm, Siv K B and Isaksen, Siv E H and Åsberg, Anders and Sollid, Ludvig M and Lundin, Knut E A},
  title = {Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70301}
}
Kostenlos starten →